BioCentury | Sep 29, 2017
Company News

Casebia, Seattle Children's partner to develop gene-edited Tregs

...selectively enhancing Treg activity in autoimmune diseases include Delinia Inc. , Caladrius Biosciences Inc. (NASDAQ:CLBS), Iltoo Pharma...
...Institute , Seattle, Wash. Business: Gene/Cell therapy, Autoimmune Mary Romeo Bayer AG Caladrius Biosciences Inc. Celgene Corp. CRISPR Therapeutics AG Delinia Inc. Iltoo Pharma Seattle...
BioCentury | Sep 27, 2017
Company News

Casebia, Seattle Children's partner to develop gene-edited Tregs

...of selectively enhancing Treg activity in autoimmune diseases include Delinia Inc., Caladrius Biosciences Inc. (NASDAQ:CLBS), Iltoo Pharma...
...this year (see BioCentury Innovations, Oct. 13, 2016) . Mary Romeo Bayer AG Caladrius Biosciences Inc. Celgene Corp. CRISPR Therapeutics AG Iltoo Pharma Seattle...
BioCentury | Oct 13, 2016
Emerging Company Profile

Turning on Tregs

...is just high enough to activate the high-affinity Treg receptor without activating the low-affinity counterpart. Iltoo Pharma...
...Companies and Institutions Mentioned Caladrius Biosciences Inc. (NASDAQ:CLBS), New York, N.Y. Delinia Inc., Cambridge, Mass. Iltoo Pharma...
Items per page:
1 - 3 of 3
BioCentury | Sep 29, 2017
Company News

Casebia, Seattle Children's partner to develop gene-edited Tregs

...selectively enhancing Treg activity in autoimmune diseases include Delinia Inc. , Caladrius Biosciences Inc. (NASDAQ:CLBS), Iltoo Pharma...
...Institute , Seattle, Wash. Business: Gene/Cell therapy, Autoimmune Mary Romeo Bayer AG Caladrius Biosciences Inc. Celgene Corp. CRISPR Therapeutics AG Delinia Inc. Iltoo Pharma Seattle...
BioCentury | Sep 27, 2017
Company News

Casebia, Seattle Children's partner to develop gene-edited Tregs

...of selectively enhancing Treg activity in autoimmune diseases include Delinia Inc., Caladrius Biosciences Inc. (NASDAQ:CLBS), Iltoo Pharma...
...this year (see BioCentury Innovations, Oct. 13, 2016) . Mary Romeo Bayer AG Caladrius Biosciences Inc. Celgene Corp. CRISPR Therapeutics AG Iltoo Pharma Seattle...
BioCentury | Oct 13, 2016
Emerging Company Profile

Turning on Tregs

...is just high enough to activate the high-affinity Treg receptor without activating the low-affinity counterpart. Iltoo Pharma...
...Companies and Institutions Mentioned Caladrius Biosciences Inc. (NASDAQ:CLBS), New York, N.Y. Delinia Inc., Cambridge, Mass. Iltoo Pharma...
Items per page:
1 - 3 of 3